Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C247-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C303-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C247-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-01 |
filingDate |
2014-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31e604a8be0cb090805881eb61d00a82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0674fd576e9898f6e7ef0d68814b55db |
publicationDate |
2016-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2016060211-A1 |
titleOfInvention |
An improved synthesis of anti-parkinson agent |
abstract |
The present invention relates to an improved process for synthesis of anti-Parkinson compound of formula (I) from commercially available (R)-benzyl glycidyl ether, wherein the compound obtained has enantiopurity greater than >98%. Formula (I) wherein R 1 and R 2 are each independently selected from hydrogen or halogen. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107857713-A |
priorityDate |
2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |